Prosecution Insights
Last updated: August 18, 2026

Examiner: KIFLE, BRUCK

Tech Center 1700 • Art Units: 1622 1624 1626 1787

This examiner grants 79% of resolved cases

Performance Statistics

79.3%
Allow Rate
+14.3% vs TC avg
1,752
Total Applications
+15.8%
Interview Lift
667
Avg Prosecution Days
Based on 1733 resolved cases, 2023–2026

Rejection Statute Breakdown

5.9%
§101 Eligibility
12.2%
§102 Novelty
12.6%
§103 Obviousness
53.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17789113 METHOD FOR MANUFACTURING 1,3-BUTYLENE GLYCOL, AND 1,3-BUTYLENE GLYCOL PRODUCT Final Rejection DAICEL CORPORATION
18715470 FUNGICIDAL COMPOSITIONS Non-Final OA SYNGENTA CROP PROTECTION AG
18551314 USE OF OXYMETHYL-MODIFIED DERIVATIVE OF QUERCETIN IN PREPARATION OF DRUG FOR INHIBITING TUMOR CELL PROLIFERATION Final Rejection ZHEJIANG UNIVERSITY
18757200 IRE1 SMALL MOLECULE INHIBITORS Non-Final OA Cornell University
18218325 METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION Non-Final OA Wisconsin Alumni Research Foundation
18551399 ANTIMICROBIAL PERFUMING CONSUMER PRODUCTS Non-Final OA Firmenich SA
18669105 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES Non-Final OA Arvinas Operations, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month